Alpha 2.0
Login Register
» Articles » PMID: 6146062

Scintigraphic Imaging of Carcinoid Tumours with 131I-metaiodobenzylguanidine

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1984 Jul 21
PMID 6146062
Citations 10
Authors
M Fischer
D Kamanabroo
H Sonderkamp
T Proske
Affiliations
Soon will be listed here.
Citing Articles

Norepinephrine Transporter as a Target for Imaging and Therapy.

Pandit-Taskar N, Modak S J Nucl Med. 2017; 58(Suppl 2):39S-53S.

PMID: 28864611 PMC: 5577620. DOI: 10.2967/jnumed.116.186833.

Fluorine-18-fluorodihydroxyphenylalanine Positron-emission Tomography Scans of Neuroendocrine Tumors (Carcinoids and Pheochromocytomas).

Zanzi I, Studentsova Y, Bjelke D, Warner R, Babchyck B, Chaly T J Clin Imaging Sci. 2017; 7:20.

PMID: 28584687 PMC: 5450503. DOI: 10.4103/jcis.JCIS_107_16.

Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

MacFarlane D, Gonin J, Wieland D, Mangner T, Froelich J, BEIERWALTES W Eur J Nucl Med. 1996; 23(2):131-40.

PMID: 8925846 DOI: 10.1007/BF01731835.

Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.

Shapiro B Ann Nucl Med. 1996; 10(1):9-12.

PMID: 8814734 DOI: 10.1007/BF03165048.

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Hoefnagel C Eur J Nucl Med. 1994; 21(6):561-81.

PMID: 7915987 DOI: 10.1007/BF00173045.